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Objectives To determine referral rates, patient characteristics, and resource utilization for patients admitted to
hospital with community-acquired lower respiratory tract infections (LRTI).
Methods Six hundred and thirteen patients, accounting for 704 LRTI episodes, were included in the study, if
the referral diagnosis was LRTI and if both signs and symptoms on admission and patient management were
consistent with this diagnosis. Patient records were abstracted to collect information on co-morbidities,
patient demographics, resource utilization, episode outcome, pharmacy prescribing and diagnostic service
utilization.
Results Annual hospital admissions for LRTI ranged from 15 per 10 000 population in the age range
16–40 years to over 300 per 10 000 in the population aged >79 years, with a population average of 62.3 per
10 000. Less than 37% of admissions were for community-acquired pneumonia and the majority of
episodes were in patients with pre-existing respiratory disease (41.2%). Marital status, gender, diabetic status,
type of infection and number of days in hospital within the past year were all significantly associated
with changes in mean length of stay.
Conclusions Hospital episodes of LRTI are seen predominantly in the over-60 age group, which account for
almost 90% of bed day utilization, yet represent only 27% of the adult population. Referral of patients to
hospital with LRTI represents a major resource implication for secondary health-care provision.
Keywords Respiratory tract infections, epidemiology, health resources
Accepted 27 June 2001
Clin Microbiol Infect 2001; 7: 666–670
INTRODUCTION
Acute lower respiratory tract infection (LRTI) is a common
reason for patients to consult their general practitioner [1].
These consultations represent a spectrum of disease, from
patients with mild post-viral symptoms to life-threatening
pneumonia. In a small percentage of patients, their illness is
severe enough to require hospitalization, and estimates for the
UK suggest that 25–50 per 10 000 adult population will require
inpatient treatment in any one year [2]. Although for many of
these patients, severity of illness will be the main factor influen-
cing the decision to admit the patient to hospital, anecdotal
evidence and data from studies where specific co-morbidities
have been studied would suggest that social factors and co-
morbid disease also influence this decision [3,4].
For an illness that results in over 100 000 hospital admissions
per year in the UK [5], there are surprisingly few published
reports describing the management or outcome for patients
hospitalized with LRTI. In contrast, there is a large volume of
literature describing specific respiratory tract illnesses, such as
community-acquired pneumonia (CAP) and acute exacerba-
tion in chronic obstructive pulmonary disease (COPD) or
asthma. However, such studies routinely utilize precise defini-
tions of disease, frequently exclude patients on the basis of co-
morbidities or age and represent only a small fraction of the
patients admitted to hospital with LRTI. Consequently, it is
difficult to estimate the total burden placed upon health-care
providers by hospital admissions for LRTI, the sectors of the
population this burden represents and the factors associated with
increases or decreases in the magnitude of the burden.
In this study, the management and resource utilization for a
sample of patients admitted to a general hospital in the UK with
a community diagnosis of LRTI during 1994–96 are reviewed.
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MATERIALS AND METHODS
Identification of cases of LRTI
Patients were identified prospectively from a review of admis-
sions to the hospital on a randomized schedule of 1 day per 5-day
block. Patients were admitted into the study if the reason given
by the physician referring the patient to hospital included LRTI,
if the signs and symptoms on admission were consistent with
LRTI and if the patient was prescribed therapy appropriate for
LRTI. Cases were validated with reference to the admission
history held in the patient’s notes, by interviewing the medical
staff responsible for the care of the patient on admission and, in a
number of cases, by examination of the patient. Other than the
questioning of clinicians to identify patients with LRTI, no
other intervention was made in the management of the patient.
There was no general case review of the medical records held for
the patients not entered into the study.
Data sources
The primary data source was the medical, nursing and phar-
macy information held in the patient notes. On discharge,
patient notes were reviewed by a single researcher, and the
following information was recorded: prior medical history of
the patient, existing co-morbidities on admission, condition of
the patient on admission, medications prescribed during the
patients stay, progression and resolution of symptoms and any
diagnostic investigations undertaken. Additional data were
collected from the central patient administration computer,
which included patient demographic information, information
on length of stay (LOS) in hospital, physicians who treated the
patient and International Classification of Disease (ICD –
release 9 and 10) codes assigned to the episode.
Data analysis
LRTI episodes were categorized utilizing the ICD coding in the
patient notes into one of four groups: (1) CAP; (2) chest
infection or acute exacerbation in the presence of asthma;
(3) chest infection or acute exacerbation in the presence of
COPD; or (4) bronchitis with no radiological evidence of
pneumonia or pre-existing respiratory disease, such as COPD
or asthma.
Distributions of LOS in hospital were assessed by examining
mean and median days; median LOS was consistently shorter
than mean LOS. For the purposes of this manuscript, only mean
LOS is reported. All analyses were repeated using median LOS
and in no instance did the results differ significantly from those
reported here.
Multivariate linear regression analysis was used to examine
the relationship of demographic factors, co-morbidities and
type of infection on LOS in all analyses. Variables included in
the models were age, gender, marital status, smoking status,
diabetic status, hypertensive status, category of LRTI and
number of days spent in hospital during the last year. Two-
tailed tests with a¼ 0.05 determined the variables remaining in
the model. All analyses were performed using SAS statistical
software version 6.12 (SAS Institute Inc., Cary, NC).
RESULTS
During the 3-year study period, 1994–96, 613 patients were
recruited into the study cohort and accounted for 704 episodes
of LRTI from a total of 3630 admissions during this period
(19.4%). There were no significant differences in the distribu-
tions for age, gender, or LOS between the study cohort and the
total LRTI admissions (data not shown).
Over one-third of the LRTI episodes were diagnosed as CAP,
irrespective of co-morbidity, while almost 40% of patients were
classed as suffering from an acute exacerbation, but not pneu-
monia, in the presence of either asthma or COPD (Table 1). In
approximately 20% of episodes there was no radiological evi-
dence of pneumonia or history of respiratory disease, such as
COPD or asthma. In general, these patients had both a higher
number and more severe co-morbidities than the other groups
(data not shown). For all patient groups, except those with an
acute exacerbation in asthma, there was an increase in hospi-
talization rates with age. The overall annual incidence of LRTI
hospitalization was 62.3 per 10 000 population and is shown in
Table 1 along with mortality rates.
For both pathology and radiology usage, a higher number of
tests was requested per LRTI episode on the first 2 days of
hospital admission than during the rest of the stay. Radiology
and pathology tests reduced to a basal level by day 5 and
remained constant through the remainder of the patient stay
(data not shown). In contrast, there was no clear influence of
LOS on the number of different medications prescribed per bed
day, which was fairly constant at 13–17 medications per day and
patients with hospital stays as long as 20 days only averaged 21
medications per day.
The relationship of demographic factors, co-morbidities and
type of infection with mean LOS are displayed in Table 2.
Marital status, gender, diabetic status, type of infection and
number of days in hospital in the past year were all significantly
associated with changes in mean LOS while controlling for age,
smoking, hypertensive status and all other variables in the
multiple linear regression model. Elimination of nonsignificant
variables from the model did not alter the results. Hospital stays
were significantly longer for men versus women (3.8 days), for
diabetics versus nondiabetics (4.5 days), and for LRTI episodes
classified as bronchitis versus those due to asthma exacerbation
(6.8 days). Mean LOS was significantly shorter for married
versus single patients (2.9 days) and episodes with a prior history
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Table1 Categorization of study episodes and estimates of the annual incidence of hospitalization for LRTI by age group





















16^39 15.1 34% 5.2 0% 0.0 45% 6.8 21% 3.1
40^49 17.5 56% 9.8 6% 1.0 21% 3.6 18% 3.1
50^59 29.4 36% 10.6 17% 5.0 21% 6.3 26% 7.5
60^69 108.6 25% 27.5 45% 48.8 10% 11.0 20% 21.2
70^79 213.5 34% 72.1 36% 76.8 12% 26.6 18% 37.9
>79 314.1 47% 67.2 21% 67.2 3% 8.4 29% 92.4
Overall 62.3 36.8% 22.9 27.4% 17.1 13.8% 8.6 22.0% 13.7
Mortality 13.5% 18.9% 8.8% 4.1% 16.1%
Table 2 The influence of patient demographics, category of LRTI and co-morbid disease onmean length of stay in days for episodes admitted with LRTI




episodes Male Female Single
With
partner CAP COPD Asthma Bronchitis Smoker Diabetes
Cardio-
vascular 0days 1^9days 10þ days
16^39 5.8 5.7 5.8 6.5 4.4 5.7 ^ 5.5 6.6 4.8 9.5 8.8 5.8 3.6 12.7
40^49 10.9 11.6 9.6 15.5 8.9 11.1 6.5 11.9 10.3 10.7 3.0 14.9 13.9 5.1 14.0
50^59 7.5 7.9 7.3 9.4 6.4 6.1 7.8 5.2 11.2 7.7 11.1 7.4 8.5 4.9 10.0
60^69 15.1 18.2 11.5 17.7 13.6 14.0 15.1 12.1 18.3 15.5 18.4 17.0 13.7 10.7 14.6
70^79 15.2 17.0 13.0 16.1 14.1 12.9 13.5 15.6 22.6 15.7 21.5 16.6 16.9 8.3 10.0
>79 18.6 18.1 19.1 19.3 17.5 16.3 12.5 14.2 27.1 16.5 23.6 20.2 19.6 11.8 12.7












































of hospital stays between 1 and 9 days in the past year versus no
hospital episodes in the past year (6.2 days).
DISCUSSION
In this study, we looked at a cohort of patients for whom the
presence of LRTI was a major factor in the decision by their
general practitioner to admit them to hospital. Although LRTI
is a group of infections normally associated with the primary-
care setting, where lack of ready access to radiology services
makes differentiation of bronchitis and pneumonia difficult, we
have used this term in the hospital setting to refer to those
patients admitted from primary care with a presumed diagnosis
of respiratory infection. Clearly, within a hospital setting with
ready access to diagnostic services for only very few admissions
will the eventual diagnosis remain uncertain. We have therefore
stratified patients into those with radiological and other signs of
pneumonia and those with an acute exacerbation, but no
radiological evidence of pneumonia, in either COPD or
asthma, in keeping with other published studies. For a sig-
nificant proportion of patients there was neither radiological
evidence to support pneumonia nor a history of pre-existing
respiratory disease. In general, these patients tended to be older,
with more extensive co-morbid diseases and prolonged diseases.
There was an overall admission rate per year for LRTI of 62.3
episodes per 10 000 population, of which over a third (37%)
were CAP. The annual prevalence of CAP was 22.9 per 10 000
population, which is comparable to published values of 25–35
per 10 000 for the USA and 10–30 per 10 000 for the UK [6,7].
A further 27% of admissions were acute exacerbations in
patients with COPD with annual prevalence rates of 48.8–
76.8 per 10 000 population in the >60 year age groups; again,
similar to published figures of 85 per 10 000 population for
Finland [8].
The length of hospital stay was chosen as the primary
indicator of resource utilization during an episode of inpatient
care as it is reliably recorded and allows comparison of data from
other sources. Less than 3% of patients were admitted to the
intensive care unit and this did not significantly alter resource
utilization when calculated by bed day. Clearly resource utiliza-
tion is not uniform during a patient’s stay, so we examined the
variation of pharmacy, radiology and pathology services
throughout a patient’s stay. These were chosen as they included
elements of medical, nursing and ancillary staff time as well as
physical resources, such as medications. As expected, both
pathology and radiology usage showed a peak of activity in
the immediate post-admission period, but by day 5, they had
settled to a constant level. In contrast, pharmacy usage was
constant throughout the duration of the patient’s stay; no
attempts were made to compare pharmacy acquisition or
administration costs. Although LOS fails to take into account
the period of high activity and resource utilization in the
immediate post-administration period, for most patients
admitted with LRTI, LOS showed good agreement with overall
resource utilization (data not shown).
The impact of co-morbidities on mean LOS for patients with
diabetes and hypertensive disease was examined, as these have
previously been reported as important determinants of LOS in
CAP [9,10]. For both co-morbidities there was a significant
(P< 0.05) increase in LOS and in previous studies this has been
postulated as due to more severe illness in these patients.
Although our data confirm these findings we would suggest
that prolonged stay is due more to complications of the co-
morbidity than to an increase in severity of the respiratory
infection. Certainly patients admitted on the basis of acute
bronchitis rather than either CAP or an acute exacerbation in
the presence of COPD or asthma had significantly longer stays
(P¼ 0.008) and more complex co-morbidities (data not
shown).
Hospitalization in the year preceding admission was exam-
ined as a general measure of the patient’s health. For patients
with no prior hospitalization mean LOS was 15.1 days, com-
pared with mean stays of 7.8 and 11.5 days for patients with
either 1–9 or >10 days hospitalization in the previous year.
Mortality was also higher in the group with no prior hospi-
talization. This would suggest that patients with 1–9 days of
prior hospitalization are being referred to hospital with less
severe disease than patients with no prior hospitalization. It is
not clear why this should be, but it could relate either to patients
with prior hospitalization seeking medical assistance earlier in
their illness or, more probably, to the decision to refer patients
to hospital being influenced by a history of hospitalization.
Certainly, some guidelines for the management of CAP include
prior hospitalization in the referral and treatment decision
processes and a history of hospitalization appears to be an
important factor in referral decisions for LRTI.
In conclusion, referral of patients to hospital with LRTI
represents a major resource implication in secondary health-
care provision. Each year within the UK there are over 250 000
adult episodes of hospitalization for LRTI, which account for
over 3 million bed days. These hospital episodes are seen
predominantly in the over 60 age group, which accounts for
89% of the total bed days yet represents only 23% of the adult
population. Of the patients referred to hospital with LRTI, only
about a third have pneumonia and most are suffering from an
LRTI compounded by co-morbidities. There is evidence that
patients are referred to hospital for reasons other than the
severity of infection and once admitted to hospital stays may
be prolonged due to social as well as medical considerations.
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